NCT07869836 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07869836
Title	BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based Therapy
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	SystImmune Inc.
Indications	bladder urothelial carcinoma renal pelvis transitional cell carcinoma ureter transitional cell carcinoma urethra transitional cell carcinoma transitional cell carcinoma
Therapies	Cisplatin + Gemcitabine Carboplatin + Gemcitabine BL-M07D1
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Central Georgia Cancer Center	RECRUITING	Macon	Georgia	31210	United States	Details
Central Georgia Cancer Center	RECRUITING	Macon	Georgia	31210	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07869836Clinical Trial Detail